
Laboratorios Farmaceuticos ROVI SA
MAD:ROVI

Intrinsic Value
The intrinsic value of one
ROVI
stock under the Base Case scenario is
81.27
EUR.
Compared to the current market price of 52.3 EUR,
Laboratorios Farmaceuticos ROVI SA
is
Undervalued by 36%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Laboratorios Farmaceuticos ROVI SA
Fundamental Analysis


Revenue & Expenses Breakdown
Laboratorios Farmaceuticos ROVI SA
Balance Sheet Decomposition
Laboratorios Farmaceuticos ROVI SA
Current Assets | 489.6m |
Cash & Short-Term Investments | 27.4m |
Receivables | 129.6m |
Other Current Assets | 332.6m |
Non-Current Assets | 342.4m |
Long-Term Investments | 19.5m |
PP&E | 286.6m |
Intangibles | 34m |
Other Non-Current Assets | 2.3m |
Free Cash Flow Analysis
Laboratorios Farmaceuticos ROVI SA
EUR | |
Free Cash Flow | EUR |
Earnings Waterfall
Laboratorios Farmaceuticos ROVI SA
Revenue
|
763.7m
EUR
|
Cost of Revenue
|
-285.4m
EUR
|
Gross Profit
|
478.3m
EUR
|
Operating Expenses
|
-298.8m
EUR
|
Operating Income
|
179.5m
EUR
|
Other Expenses
|
-42.7m
EUR
|
Net Income
|
136.9m
EUR
|
ROVI Profitability Score
Profitability Due Diligence
Laboratorios Farmaceuticos ROVI SA's profitability score is 71/100. The higher the profitability score, the more profitable the company is.

Score
Laboratorios Farmaceuticos ROVI SA's profitability score is 71/100. The higher the profitability score, the more profitable the company is.
ROVI Solvency Score
Solvency Due Diligence
Laboratorios Farmaceuticos ROVI SA's solvency score is 85/100. The higher the solvency score, the more solvent the company is.

Score
Laboratorios Farmaceuticos ROVI SA's solvency score is 85/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ROVI Price Targets Summary
Laboratorios Farmaceuticos ROVI SA
According to Wall Street analysts, the average 1-year price target for
ROVI
is 77.97 EUR
with a low forecast of 65.55 EUR and a high forecast of 96.6 EUR.
Dividends
Current shareholder yield for ROVI is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
ROVI
stock under the Base Case scenario is
81.27
EUR.
Compared to the current market price of 52.3 EUR,
Laboratorios Farmaceuticos ROVI SA
is
Undervalued by 36%.